substance misuse

A drug is a chemical substance that acts on the brain and nervous system, changing a person’s mood, emotion or state of consciousness. Drugs are often classified by the effect they have.
Stimulants, such as cocaine, make people feel full of energy. Depressants (or sedatives), such as heroin, make people feel relaxed. Hallucinogens, such as LSD, make people see, feel or hear things that are not real. Drug or substance misuse is when a person regularly takes one or more drugs to change their mood, emotion or state of consciousness.

Our substance misuse Blogs

Inclusion health: a new perspective on health inequalities?

imani-597657-unsplash

Noortje Uphoff writes her debut elf blog on a recent paper in The Lancet, which looks at what works in inclusion health; providing an overview of effective interventions for marginalised and excluded populations.

[read the full story...]

Moderate and heavy alcohol consumption: what impact on later life brain and cognition?

willian-west-342225-unsplash

Sally Adams summarises a recent clinical review in Evidence Based Mental Health on the effects of drinking alcohol on late-life brain and cognition.

Follow #EBMHchat today from 3pm for an expert Google Hangout on this paper.

[read the full story...]

Alcohol is the number one modifiable risk factor for dementia

huy-phan-587849-unsplash

Marie Crabbe looks at a recent retrospective cohort study in The Lancet Public Health which explores the contribution of alcohol use disorders to the burden of dementia in France.

[read the full story...]

Non-medical use of prescription drugs #NonMedicalDrugs

playmobil-451203_1280

Ian Hamilton and Julia Buxton from the University of York preview the #NonMedicalDrugs event that will take place in York on Friday 16th March 2018.

The meeting will bring together people who can offer personal and professional insights of the extent of the issue and how we can support people who develop problems.

[read the full story...]

WHO cares? Treatment coverage for substance use disorders: results from 26 countries

drugs-planet

Ian Hamilton reports on an analysis of data from the World Mental Health Surveys, which estimates treatment coverage for people with substance use disorders.

[read the full story...]

Prevention and early intervention for youth mental illness: how should we focus our limited resources? #MQScienceMeeting

craig-whitehead-431483

André Tomlin presents a summary of all the evidence we have highlighted over the last 3 years relating to prevention and early intervention for mental illness in young people.

This blog accompanies the #MQScienceMeeting coverage this week, which you can follow on Twitter.

[read the full story...]

Opiate substitution therapy: supervised-consumption vs take-home doses

methadone

Vicky Carlisle publishes her debut elf blog on a Cochrane review of supervised dosing with long-acting opioid medication in the management of opioid dependence.

[read the full story...]

Which personality traits may protect us from alcohol use disorder?

eeshan-garg-263528

Andrew Jones summarises a recent systematic review and meta-analysis of alcohol treatment outcome, which identifies a range of personality traits that are associated with relapse.

[read the full story...]

Dual diagnosis guidance: money talks when it comes to drugs, alcohol and mental illness

alice-pasqual-258250 (1)

Ian Hamilton shares his thoughts on the new PHE dual diagnosis guidance: Better care for people with co-occurring mental health and alcohol/drug use conditions.

[read the full story...]

Novel Psychoactive Substances: bridging the knowledge gap

valor-kopeny-31405

Derek Tracy takes a first look at the Novel Psychoactive Substances in the UK Project; an NIHR-funded empirical and conceptual review that recommends research priorities in the field.

[read the full story...]